Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

Living with Dementia

department of psychiatry and psychotherapy1 - morphometry1 - emotional distress1 - agitation2 - fuller1 - subjective cognitive decline1 - progression of parkinson's1 - loss of judgement1 - high blood pressure7 - cognitive changes1 - restlessness1 - dimebon1 - apoplectic dementia1 - development of parkinson's1 - amyloid β1 - parkinson's diagnosis1 - remarriage1 - difficulties with swallowing1 - emission computed tomography1 - parkinson's disease risk1 - alzheimer2 - alcohol-related brain damage1 - aids related dementia1 - causes of dementia1 - depressive pseudodementia1 - solanezumab1 - virtual reality1 - memory lapses2 - disorders of blood vessels1 - genetic evidence1 -